HomeProductsBioactive CompoundsNF-kB SignalingNF-??BRoxithromycin
Chemical structure of CAS 80214-83-1

Roxithromycin

In Stock•Starting at $6 for 1 g•Purity ≥ 95%
CAS No.80214-83-1
MDL No.N/A
MFC41H76N2O15
MW837.00
InChI KeyRXZBMPWDPOLZGW-XMRMVWPWSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 g95%$6In Stock
5 g95%$14In Stock
25 g95%$45In Stock
100 g95%$159In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Roxithromycin is a semisynthetic derivative of erythromycin A, functioning as an antibacterial drug. It is an erythromycin derivative, a macrolide, and a semisynthetic compound.

CAS No.80214-83-1
Product NameRoxithromycin

Associated Conditions

bacterial disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells.

Journal of periodontal research • Vol. 39, Issue 1 • 2004
PMID: 14687228DOI: 10.1111/j.1600-0765.2004.00704.x

Roxithromycin induced torsade de pointes in a patient with complex congenital heart disease and complete atrioventricular block.

Pacing and clinical electrophysiology : PACE • Vol. 26, Issue 6 • 2003
PMID: 12822762DOI: 10.1046/j.1460-9592.2003.t01-1-00204.x

Roxithromycin promotes lymphocyte apoptosis in Dermatophagoides-sensitive asthma patients.

European journal of pharmacology • Vol. 474, Issue 2-3 • 2003
PMID: 12921874DOI: 10.1016/s0014-2999(03)01998-8

Reversible anosmia after amikacin therapy.

Archives of otolaryngology--head & neck surgery • Vol. 129, Issue 12 • 2003
PMID: 14676161DOI: 10.1001/archotol.129.12.1331

Documentation

Similar Products